APMAdvances in Precision Medicine2424-85922424-9106Bio-Byword Scientific Publishing Pty. Ltd.10.18063/APM.v10i4.1033ArticleGeneral Diabetes Treatment Options and Impact on Patients’ Blood Sugar Levelshttps://artdesignp.com/journal/APM/10/4/10.18063/APM.v10i4.1033FeiShaohua20251042025-12-20Objective: To explore the effect of general comprehensive treatment program on blood sugar control and insulin dosage in patients with type 2 diabetes. Methods: 86 patients with type 2 diabetes admitted from January 2022 to December 2023 were selected and randomly divided into a control group of 43 cases (conventional hypoglycemic regimen) and an observation group of 43 cases (general comprehensive intervention). The glycated hemoglobin (HbA1c), fasting blood glucose (FPG), 2-hour postprandial blood glucose (2hPG), insulin dosage, and occurrence of adverse reactions were compared between the two groups of patients after 3 months of treatment. Results: Before intervention, the HbA1c of the two groups of patients (control group was 8.42 ± 1.35%, observation group was 8.38 ± 1.41%), FPG (control group was 9.25 ± 1.72 mmol/L, observation group was 9.18 ± 1.68 mmol/L) difference was not statistically significant (p > 0.05); after intervention, the HbA1c of the observation group dropped to 7.02 ± 0.93%, which was significantly lower than the 7.89 ± 1.12% of the control group (p < 0.05). FPG (6.85 ± 1.02 mmol/L) and 2hPG (9.06 ± 1.34 mmol/L) were lower than those of the control group (7.94 ± 1.25). mmol/L, 10.87 ± 1.59 mmol/L) decreased more significantly (p < 0.05). The average daily insulin consumption of the observation group was 32.15 ± 6.84 U, which was less than 41.27 ± 7.53 U of the control group (p < 0.05). The total effective rate of the observation group was higher than that of the control group, and the adverse reactions were lower than that of the control group (p < 0.05). Conclusion: A comprehensive treatment program can effectively improve blood sugar control, reduce insulin dependence, and reduce the risk of hypoglycemia in patients with type 2 diabetes.General treatment plan for diabetes, Blood sugar level, Impact

[1] Mo J, He D, Peng L, et al., 2023, Application of CBL Combined with MDT Teaching Model in General Chronic Disease Management Teaching for Patients with Type 2 Diabetes and Complications. She Zhi, 35(03): 419–421. [2] Lin K, Yao M, Chen Z, et al., 2023, Conceptual Framework and Coping Methods for the Treatment Burden of Type 2 Diabetes: Based on Video Recording Analysis. Chinese General Medicine, 26(34): 4302–4307. [3] Pan D, Ou Y, Zhu J, et al., 2022, Progress in the Application of General Medicine Management Model in Patients with Type 2 Diabetes. Chinese Medical Sciences, 12(12): 33–36. [4] Li Y, Liao W, Mo S, et al., 2022, Clinical Study of General Medicine Management Model in the Treatment of Type 2 Diabetes. Chinese Prescription Drugs, 20(04): 157–158. [5] Fu X, Wang Y, 2022, Analysis of Effective Methods for the Holistic Treatment of Diabetic Foot by Integrating Traditional Chinese and Western Medicine. Diabetes New World, 25(02): 179–182. [6] Yang S, Zhang X, Zhou M, et al., 2022, Research on the Impact of Core Characteristic Functions of General Practice on Treatment Compliance of Diabetic Patients. Chinese General Medicine, 25(01): 62–69. [7] Guan J, 2021, The Application Value of the General Medicine Model in the Treatment of Patients with Type 2 Diabetes. Medical Frontiers, 11(18): 179–180. [8] Wang G, 2021, Analysis of the Treatment Effect of General Medicine Model for Patients with Type 2 Diabetes. Chinese Medicine and Clinic, 21(12): 2091–2093.